Analysis of nosocomial outbreaks with multiply and methicillin-resistant Staphylococcus aureus (MRSA) in Germany: implications for hospital hygiene

Infection. 1994:22 Suppl 2:S128-34. doi: 10.1007/BF01793577.

Abstract

Two outbreaks of nosocomial infections with MRSA, one in a urological unit in connection with transurethral prostatectomy and the other in an orthopaedic clinic with infections after implantation of prosthetic hips, have been analyzed on the basis of typing MRSA by phage-patterns, plasmid profiles and genomic DNA fragment patterns. Main reasons for these outbreaks were obviously mistakes in hospital hygiene and an inappropriate antibiotic prophylaxis (in the first outbreak a quinolone over about 7 days, in the second a third generation cephalosporin). Both outbreaks could be stopped by measures of hospital hygiene including isolated or cohort nursing of affected patients, and change in antibiotic prophylaxis. Intensive care units (ICUs) are more often affected by MRSA than other clinical settings. As described by the example of an outbreak with MRSA in a municipal hospital, ICUs can play a special role in intrahospital spread of MRSA. The recently observed inter-regional clonal interhospital dissemination of MRSA in Germany is mainly due to a transfer of patients between hospitals; prewarning of the hospital of destination and a number of hygiene measures can prevent further spread.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Bacteriophage Typing
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology*
  • Cross Infection / microbiology*
  • Cross Infection / transmission
  • Disease Outbreaks*
  • Drug Resistance, Multiple*
  • Genome, Bacterial*
  • Germany / epidemiology
  • Hip Prosthesis / adverse effects*
  • Humans
  • Hygiene
  • Infection Control* / methods
  • Intensive Care Units
  • Male
  • Methicillin Resistance*
  • Patient Transfer
  • Phenotype
  • Plasmids
  • Premedication / methods
  • Prostatectomy / adverse effects*
  • Prosthesis-Related Infections / drug therapy
  • Prosthesis-Related Infections / epidemiology*
  • Prosthesis-Related Infections / microbiology*
  • Prosthesis-Related Infections / transmission
  • Risk Factors
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / epidemiology*
  • Staphylococcal Infections / microbiology*
  • Staphylococcal Infections / transmission
  • Staphylococcus aureus* / classification
  • Staphylococcus aureus* / genetics

Substances

  • Anti-Bacterial Agents